Neoplasms: all 9,617 studies

Page 61 of 97. Open to participants first (2,509), then studies with results posted, then the rest; newest registration first within each.

• Patient Portal and Navigation Program in Providing Information for Asian American Cancer PatientsCompletedNCT03867916Not applicable
• Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)Active, not recruitingNCT03865082Phase 2
• A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2)CompletedNCT03861793Phase 1/2
• TR1801-ADC in Patients With Tumors That Express c-MetSuspendedNCT03859752Phase 1
• A Study of SHR-A1403 in Patients With Advanced Solid TumorCompletedNCT03856541Phase 1
• Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic VisitsCompletedNCT03856060Not applicable
• HemosprayTM for Gastrointestinal Bleeding From CancerStatus unknownNCT03855904Not applicable
• Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDSStatus unknownNCT03855371Phase 1
• IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.Status unknownNCT03854838Phase 2
• Multiparametric Magnetic Resonance Imaging Versus Fine Needle Aspiration Cytology for Parotid Gland NeoplasmsStatus unknownNCT03849482
• A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid TumorsActive, not recruitingNCT03845166Phase 1
• A Study Evaluating the Safety, Tolerability of LPM3480226 Tablets in Patients With Advanced Solid TumorsStatus unknownNCT03844438Phase 1
• An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical TrialActive, not recruitingNCT03844048Phase 3
• Expanded Access of Vigil in Solid TumorsTemporarily not availableNCT03842865
• FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid TumorsCompletedNCT03841110Phase 1
• GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT03840421Phase 3
• Whole-Exome Sequencing (WES) of Intraductal Neoplasms of the Bile Duct (IPNB)Status unknownNCT03838913
• Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal CarcinomaStatus unknownNCT03837808Phase 3
• TRANSfusion in Patients With Onco-hematological Malignancies ResusciTated From Septic ShockCompletedNCT03837171Phase 3
• Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic CancerStatus unknownNCT03835949Phase 1
• Endoscopic Ultrasound-guided RadioFrequency Ablation for the Treatment Pancreatic NeuroEndocrine NeoplasmsCompletedNCT03834701Not applicable
• A Trial of AVID200, a Transforming Growth Factor β (TGFβ) Inhibitor, in Patients MalignanciesCompletedNCT03834662Phase 1
• Resistance Inspiratory Muscle Training for Patients With Thoracic MalignanciesCompletedNCT03834116Not applicable
• Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer PatientsStatus unknownNCT03831633Phase 4
• SD-101 and BMS-986178 in Treating Patients With Advanced or Metastatic Solid MalignanciesCompletedNCT03831295Phase 1
• Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer DiagnosisCompletedNCT03830619
• THrombo-Embolic Event in Onco-hematologyCompletedNCT03826043Not applicable
• Expanded Access Program (EAP) for Participants With Advanced Cancers and Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations Who Have Exhausted All Treatment OptionsApproved for marketingNCT03825484
• Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid TumorsActive, not recruitingNCT03821935Phase 1
• Infusion of Donor Derived Cytokine Induced Killer (CIK) Cells in Hematological Patients Relapsed After Haploidentical Stem Cell TransplantStatus unknownNCT03821519Phase 1/2
• Chromogranin A as Blood Marker in Cancer PatientsCompletedNCT03817866
• A Study of PD1 Combined With Dc-cik in the Treatment of Solid TumorsStatus unknownNCT03815630Early Phase 1
• A Study of PD1 Combined With DC-NK Cell in the Treatment of Solid TumorsStatus unknownNCT03815084Early Phase 1
• Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid TumorsCompletedNCT03810742Phase 1
• Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)Active, not recruitingNCT03809377
• Effectiveness of an Online Intervention Targeting Cancer-related FatigueTerminatedNCT03809130Not applicable
• A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Asian Patients With Advanced CancerCompletedNCT03808870Phase 1
• Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell TransplantWithdrawnNCT03807063Phase 1
• Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)CompletedNCT03806712
• Development and Evaluation of THRIVECompletedNCT03806140Not applicable
• Endoscopic Full-Thickness Resection In ColonStatus unknownNCT03803891
• Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver TransplantationCompletedNCT03803436Phase 2
• Evolution of Thromboelastography During Tranexamic Acid TreatmentCompletedNCT03801122Phase 2
• Early Palliative Care for Patients With Haematological MalignanciesStatus unknownNCT03800095Phase 3
• A Study of ASP1951 in Subjects With Advanced Solid TumorsTerminatedNCT03799003Phase 1
• CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic MalignanciesStatus unknownNCT03795779Early Phase 1
• Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid TumorsStatus unknownNCT03792958Phase 1
• Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)CompletedNCT03792516Phase 1
• Magnetic Compressive Anastomosis for Biliojejunostomy and Pancreaticojejunostomy During Whipple's ProcedureStatus unknownNCT03792048Not applicable
• Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor MalignanciesCompletedNCT03790488Phase 1
• Failure to Adjuvant Therapy After Pancreatic Resection for Pancreatic CancerCompletedNCT03788382
• A Real World Study of Anti-PD-1/PD-L1 Antibodies for the Treatment of Advanced Solid TumorsStatus unknownNCT03787953
• Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1Active, not recruitingNCT03785249Phase 1/2
• A Phase I Study of SOR-C13 in Patients With Advanced Solid TumorsCompletedNCT03784677Phase 1
• Phase 1 Study in Patients With Advanced and/or Refractory Solid Malignancies to Evaluate the Safety of ATOR-1015CompletedNCT03782467Phase 1
• Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered TumorsCompletedNCT03780517Phase 1
• Treg, Th17 Cells, NKT in Epithelial Ovarian TumorCompletedNCT03779399
• Emotional Evaluation and Reconstructed Breast SatisfactionStatus unknownNCT03777852Not applicable
• Evaluation of End of Life Quality of CareCompletedNCT03775304
• SHR-1701 in Subjects With Metastatic or Locally Advanced Solid TumorsStatus unknownNCT03774979Phase 1
• MS Detection of Somatic Mutations in Hematological MalignanciesStatus unknownNCT03771079
• A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab StudyActive, not recruitingNCT03768063Phase 3
• A Study Evaluating the Safety, Tolerability, and Initial Efficacy of Recombinant Human Anti-cluster Differentiation Antigen 47 (CD47) Monoclonal Antibody Injection (IBI188) in Patients With Advanced Malignant Tumors and LymphomasCompletedNCT03763149Phase 1
• Psychosocial Intervention in Latino Patients with Advanced CancerCompletedNCT03763032Not applicable
• First in Human Study of IBI101 in Chinese Subjects With Advanced Solid TumorsCompletedNCT03758001Phase 1
• A Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Anti-PD-1 Antibody (HLX10) in Combination With Avastin Biosimilar (HLX04) in Patients With Advanced Solid TumorsStatus unknownNCT03757936Phase 1
• TAK-659 and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT03756818Phase 1
• Contribution of Hypnosis to Anxiety and Pain in Brachytherapy PatientsCompletedNCT03755895Phase 2
• Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17Active, not recruitingNCT03755804Phase 2
• Improving Quality and Consistency in Family Education Prior to First Discharge Following Pediatric Cancer DiagnosisCompletedNCT03752801
• Safety of EUS-FNA for Pancreatic Solid-Pseudopapillary Neoplasm (SPN) Before Surgical Resection: the SPN-GRAPHE SeriesCompletedNCT03749941
• HPV in Blood Samples From Cervical Cancer Patients.CompletedNCT03749720Not applicable
• A Study of the Role of Circulating Tumor DNA in Predicting the Likelihood of Organ Preservation After Clinical Complete Response to Neoadjuvant Therapy for Rectal CancerWithdrawnNCT03749083
• Study of PD-1 Gene-knocked Out Mesothelin-directed CAR-T Cells With the Conditioning of PC in Mesothelin Positive Multiple Solid TumorsStatus unknownNCT03747965Phase 1
• Can Electronic Information Kiosks Enhance Patient Accrual for Cancer Clinical Trials? A Pilot and Feasibility StudyCompletedNCT03747276Not applicable
• Study of ImmunoPet Imaging of PD-L1 in Tumors Using 89Zr-DFO-REGN3504 in Adult Participants With Advanced PD-L1 Positive MalignanciesTerminatedNCT03746704Phase 1
• Supportive Care Service Availability for Cancer Caregivers in Community Oncology PracticesCompletedNCT03746314
• A Efficacy and Safety Study of Composite Gel Containing Black Raspberry Extract in Removing HPV From Patients With Cervical Intraepithelial Neoplasia(CIN) After Cervical ConizationStatus unknownNCT03745846Phase 2
• Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)CompletedNCT03745378
• A Study of CS1001 in Subjects with Advanced Solid TumorsCompletedNCT03744403Phase 1
• Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic NeoplasiaTerminatedNCT03743961
• Early Palliative Care and Hematological Cancer PatientsTerminatedNCT03743480Not applicable
• Quantitative HPV Genotyping in Screening of Anal Intraepithelial Neoplasia in HIV-positive PatientsTerminatedNCT03742375Not applicable
• Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain MetastasesActive, not recruitingNCT03741673Phase 3
• Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood CancerWithdrawnNCT03739606Phase 2
• Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade GliomaCompletedNCT03739372Not applicable
• Treatment of the Pancreatic Stump With Neoprene®-Based Glue After High-risk PancreatoduodenectomyCompletedNCT03738787Phase 2
• Study of CS3006 in Subjects With Locally Advanced or Metastatic Solid TumorsCompletedNCT03736850Phase 1
• A Phase I Study of MEDI9447 (Oleclumab) in Japanese PatientsCompletedNCT03736473Phase 1
• GX-I7 With Cyclophosphamide in Patients With Metastatic or Recurrent Solid TumorsCompletedNCT03733587Phase 1
• Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCTStatus unknownNCT03733340Phase 2/3
• CT-Guided Adaptive Radiation Therapy Combine With Anti-PD-1 Antibody Adjuvant Immunotherapy for Thoracic Cancer PatientsStatus unknownNCT03732430Phase 2
• Establishment of Abbreviated Pancreatobiliary MRI ProtocolCompletedNCT03731819Not applicable
• Phase 1 Study of ONO-7475 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid TumorsCompletedNCT03730337Phase 1
• the Efficacy and Safety of Sugammadex in Children 0-2 Years OldStatus unknownNCT03728543Phase 2/3
• Yoga for Solid TumorWithdrawnNCT03728205Not applicable
• RACIN in Patients With Advanced TIL-negative Solid TumorsCompletedNCT03728179Phase 1
• Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic MalignanciesTerminatedNCT03727009
• The Feasibility of Delivering Consumer-based Meditation Applications to Myeloproliferative Neoplasm PatientsCompletedNCT03726944Not applicable
• A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Patients With Advanced CancerCompletedNCT03726294Phase 1

← Neoplasms overview